Sodium glucose cotransporter 2 inhibitors and the risk of respiratory outcomes among patients with type 2 diabetes: A nationwide cohort study

被引：0
|
作者：
Jeong, Han Eol [1 ]
Park, Sohee [2 ]
Noh, Yunha [3 ]
Filion, Kristian [4 ]
Yu, Oriana Hoi Yun [4 ]
Jang, Seung Hun [5 ]
Shin, Ju-Young [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Pharm, Seoul, South Korea
[2] SKKU, Sch Pharm, Seoul, South Korea
[3] Sungkunkwan Univ, Seoul, South Korea
[4] McGill Univ, Montreal, PQ, Canada
[5] Hallym Univ, Coll Med, Hallym Univ Sacred Heart Hosp, Dept Internal Med, Chunchon, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
728
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [41] Sodium-Glucose Cotransporter 2 Inhibitors Improve Nocturnal Glucose Variability in Patients with Type 2 Diabetes
    Kakutani, Yoshinori
    Morioka, Tomoaki
    Ueda, Shuko
    Kawarabayashi, Reina
    Nakamura, Miyuki
    Asada, Mariko
    Yamazaki, Yuko
    Motoyama, Koka
    Mori, Katsuhito
    Shioi, Atsushi
    Shoji, Tetsuo
    Emoto, Masanori
    Inaba, Masaaki
    DIABETES, 2017, 66 : A240 - A240
  • [42] Sodium-Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study
    Chang, Hao-Chih
    Kuo, Tzu-Ting
    Chen, Yun-Yu
    Lin, Yenn-Jiang
    Chang, Hung-Yu
    Hung, Chung-Lieh
    Chung, Fa-Po
    DIABETES CARE, 2022, 45 (09) : E129 - E130
  • [43] Erectile Dysfunction Risk Among Patients With Diabetes Mellitus Using Sodium-Glucose Cotransporter 2 Inhibitors
    Hu, Wei-Syun
    Lin, Cheng-Li
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 84 (05) : 545 - 549
  • [44] Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: A multi-institutional cohort study in Taiwan
    Su, Yu-Chen
    Shao, Shih-Chieh
    Lai, Edward Chia-Cheng
    Lee, Chaw-Ning
    Hung, Ming-Jui
    Lai, Chi-Chun
    Hsu, Sheng-Min
    Hung, Jia-Horung
    DIABETES OBESITY & METABOLISM, 2021, 23 (09): : 2067 - 2076
  • [45] Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes
    Lam, Steven Ho Man
    Alam, Uazman
    Lip, Gregory Yoke Hong
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 223 : 183 - 185
  • [46] Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes in Patients with Acute Coronary Syndrome and Type 2 Diabetes
    Xie, Han
    Jiang, Ming-Jian
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 4377 - 4386
  • [47] Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan
    Das, Bhagwan
    Sheikh, Aisha
    Ahmed, Bilal
    Islam, Najmul
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (05) : 1342 - 1346
  • [48] SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS AND REDUCED RISK OF LIVER CANCER IN PEOPLE WITH TYPE 2 DIABETES: A POPULATION-BASED COHORT STUDY
    Huang, Pin-Chia
    Ma, Kevin Sheng-Kai
    HEPATOLOGY, 2023, 78 : S1925 - S1926
  • [49] Sodium-Glucose Cotransporter 2 Inhibitor Use and Risk of Dementia and Parkinson's disease among Patients with Type 2 Diabetes-A Longitudinal, Nationwide, Population-Based Cohort Study
    Kim, Hae Kyung
    Biessels, Geert J.
    Yu, Minheui
    Bae, Jihoon
    Choi, Arim
    Lee, Minyoung
    DIABETES, 2024, 73
  • [50] Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus
    Kambara, Takahiro
    Shibata, Rei
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    Murohara, Toyoaki
    Ajioka, Masayoshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (01) : 108 - 114
12345